Questcor Pharmacueticals (QCOR) Misses Q1 EPS by 21c

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q1 EPS of $1.40, $0.21 worse than the analyst estimate of $1.61. Revenue for the quarter came in at $227.1 million versus the consensus estimate of $239.81 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Change in Nonfarm Payrolls (Aug) 162K vs 55K Expected, Unemployment Rate 4.1%
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes